UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

~~Washington~~WASHINGTON, D.C. 20549

_________________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(Dd) of the ~~Securities Exchange Act of 1934~~

Securities ~~Date~~Exchange ofAct ~~Report (Date~~ of ~~earliest event reported): November 8, 2011~~1934

~~Commission File Number: 000-50029~~_________________

~~CHINA~~Date of ~~HEALTH~~Report ~~RESOURCE~~(Date of earliest event reported): June 19, ~~INC.~~2013

~~(Name~~China Health ofResource, ~~Small Business Issuer in its Charter)~~Inc.

Delaware	73-1629948
(State or Other Jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

(Exact Name of Registrant as Specified in its Charter)

~~343~~000-50029 ~~Sui~~(Commission ~~Zhou~~file ~~Zhong Road~~number)

~~Suining,~~CHINA ~~Sichuan~~HEALTH ~~Province~~RESOURCE, PINC.R. ~~China~~(Exact name of registrant as specified in its charter)

(Address of Principal Executive Offices)

DELAWARE	73-1629948
(State or other jurisdiction	(IRS Employer
of incorporation or organization)	Identification No.)

+(86-825) 239-1788

343 Sui Zhou Zhong Road
Suining, Sichuan Province, P.R. China	629000
(Address of principal executive offices)	(zip code)

+(~~Issuer~~86-825) 239-1788 (Registrant’s ~~Telephone~~telephone ~~Number~~number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

~~[ ]~~o Written ~~communication~~communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c))

~~[ ] Soliciting Material pursuant to Rule 14a-12 under the Exchange~~Item ~~Act~~3.02 Unregistered ~~(17~~Sales ~~CFR~~of ~~240~~Equity Securities.~~14a-12)~~

~~[ ]~~On June ~~Pre-commencement~~19, ~~communications~~2013, ~~pursuant~~the toBoard ~~Rule~~of ~~14d-2~~Directors of China Health Resource Inc. (bthe “Company”) ~~under~~approved a securities purchase agreement (the ~~Exchange~~“Securities ~~Act~~Purchase Agreement”) with certain accredited investor (17the ~~CFR~~“Investor”) pursuant ~~240~~to which we issued the Investor an aggregate of 50,000,000 shares (the “Investor Shares”) of our common stock, par value $0.~~14a-12~~007 per share (“Common Stock”) in exchange for aggregate consideration of $350,000 (the “Private Placement”). The Company entered the Securities Purchase Agreement with the Investor on June 19, 2013.

~~[ ]~~The Securities ~~Pre-commencement~~Purchase ~~communication~~Agreement ~~pursuant~~allows for the sale of up to ~~Rule~~$350,000 ~~13e-4©~~of shares of Common Stock in one closing until July 19, 2013. ~~under~~The Securities Purchase Agreement contains representations, warranties and covenants of the ~~Exchange~~Investors ~~Act~~and ~~(17~~us ~~CFR~~that ~~240~~are typical for transactions of this type.~~13e-4(c))~~

~~ITEM~~The Investor 1Shares issued to the Investors were not registered under the Securities Act, or the securities laws of any state, and were offered and sold in reliance on the exemption from registration under the Securities Act, provided by Section 4(2) and Regulation D (Rule 506) and Regulation S under the Securities Act.01 ~~ENTRY~~Each ~~INTO~~Investor Awas ~~MATERIAL~~an ~~DEFINITIVE~~accredited ~~AGREEMENT~~investor (as defined by Rule 501 under the Securities Act) and a non-U.S. persons, as defined in Rule 902(k) of Regulation S at the time of such Investor’s respective Private Placement. In addition, the Company’s shares will be issued without registration under Section 5 of the Securities Act in reliance on the exemption from registration contained in Section 4(2) of the Securities Act. Specifically, (1) the Company had determined that the Investor was knowledgeable and experienced in finance and business matters and thus they are able to evaluate the risks and merits of acquiring the Investor Shares; (2) the Investor had advised the Company that the Investor was able to bear the economic risk of purchasing the Company’s common stock; (3) the Company had provided the Investor with access to the type of information normally provided in a prospectus; and (4) the Company did not use any form of public solicitation or general advertising in connection with the issuance of the shares.

~~China~~The foregoing ~~Health~~summaries ~~Resource~~of ~~Receives~~the ~~Letters~~Securities ofPurchase Agreement are not complete, and are qualified in their entirety by reference to ~~Intent~~the ~~Totaling~~full ~~Over~~text $7of the agreements that are attached as exhibits to this Current Report on Form 8-K.5 ~~Million~~Readers should review those agreements for a more complete understanding of the terms and conditions associated with this transaction.

~~SUINING, China, November 8, 2011 – China Health Resource,~~Item ~~Inc~~9.01 ~~(OTCBB:CHRI)~~Financial ~~through~~Statements ~~its~~and ~~subsidiaries, has successfully concluded negotiations for new purchasing Letters of Intent (LOI) for a total of over 45 million RMB (US$7~~Exhibits.~~5 Million).~~

~~The purchase LOIs were based upon contacts made during the 13th West China International Exhibition~~ (~~CIE~~d) ~~Fair held at Chengdu, Sichuan where CHRI participated with other 4,564 other companies. The Company has now concluded definitive agreements.~~Exhibits

CHRI, thru its subsidiary, Suining Yinfa Daharian Angelica Root (DAR) Industrial Co. Ltd. (Yinfa), participated in the exhibition under its special designation as a provincial agricultural Dragonhead Enterprise. CHRI represents the only GAP DAR under the Chuan Baizhi™ national trademark in China at the event.

Exhibit Number		Description
10.1		Securities Purchase Agreement, dated as of June 19, 2013, by and among China Health Resource, Inc. and certain purchaser set forth therein.

“We are pleased to be a Dragonhead Enterprise – a prestigious designation which provides CHRI with recognition and access to important government officials” said Mr. Jiayin Wang, Chairman and CEO of CHRI.SIGNATURES

AtPursuant to the ~~CIE~~requirements ~~Fair,~~of ~~Mr.~~the ~~Wang~~Securities ~~showcased~~Exchange ~~the~~Act ~~company~~of ~~products~~1934, ~~it’s special~~the ~~GAP~~registrant ~~DAR~~has ~~produce~~duly ~~and~~caused ~~summarized~~this ~~recent~~report ~~developments for CHRI~~ to abe ~~select~~signed ~~group~~on ofits ~~VIP’s including Suining City Party~~behalf ~~Secretary~~by ~~Mr. Baohua Qu and~~ the ~~Chuanshan~~undersigned ~~District~~hereunto ~~Manager~~duly Mrauthorized. ~~Linlin Zhou, provincial agricultural department officials, other Suining City government senior officials, and administrative executives and scholars of the Chengdu TCM University.~~

CAUTIONARY STATEMENT REGARDING FORWARD LOOKING INFORMATION

	CHINA HEALTH RESOURCE, INC.

Dated: June 25, 2013	By:	/s/ Jiayin Wang
		Name: Jiayin Wang
		Title: Chief Executive Officer

The announcement may contain forward-looking statements that involve risks and uncertainties which may cause the actual results, performance and achievements or the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. The issuer’s actual results could differ significantly from those discussed herein. These include statements about our expectations, beliefs, intentions or strategies for the future, which we indicate by words or phrases such as “anticipate,” “expect,” “intend,” “plan,” “will,” “we believe,” “the Company believes,” “management believes” and similar language. We base our forward-looking statements on information currently available to us, and we assume no obligation to update them. More information is included in the company’s filings with the Securities and Exchange Commission, and may be accessed through the SEC’s website at http://sec.gov.

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	CHINA HEALTH RESOURCE, INC.
Dated: November 8, 2011	By: /s/ Wang, Jiayin
	Wang, Jiayin
	Chief Executive Officer and Director
	(Principal Executive Officer)

Filing Compare · CHINA HEALTH RESOURCE, INC.